PDL BioPharma, Inc. Contract with Customer, Asset, after Allowance for Credit Loss
PDL BioPharma, Inc. had Contract with Customer, Asset, after Allowance for Credit Loss of $0 as of 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Balance Sheet › Assets
us-gaap:ContractWithCustomerAssetNet · last filed 2021-03-29
- 2020-12-31: Contract with Customer, Asset, after Allowance for Credit Loss $0.00.
- 2020-09-30: Contract with Customer, Asset, after Allowance for Credit Loss $0.00.
- 2020-06-30: Contract with Customer, Asset, after Allowance for Credit Loss $4.07M.
- 2020-03-31: Contract with Customer, Asset, after Allowance for Credit Loss $4.83M.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss | Contract with Customer, Asset, after Allowance for Credit Loss as first filed |
|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-29 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $4.07M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $4.83M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $3.51M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $3.85M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $3.21M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $5.36M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.60M 8-K · filed 2020-06-29 | |
| 2018-09-30 | $3.11M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $19.97M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $23.17M 10-Q · filed 2018-05-09 | |
| 2018-01-01 | $0.00 10-Q · filed 2018-11-07 | $30.77M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-15 |